Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 8/2015

Ausgabe 8/2015

Inhaltsverzeichnis ( 13 Artikel )

01.08.2015 | Review | Ausgabe 8/2015

Hepatic myeloid-derived suppressor cells in cancer

José Medina-Echeverz, Tobias Eggert, Miaojun Han, Tim F. Greten

01.08.2015 | Original Article | Ausgabe 8/2015

Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity

Masato Muto, Muhammad Baghdadi, Ryuji Maekawa, Haruka Wada, Ken-ichiro Seino

01.08.2015 | Original Article | Ausgabe 8/2015 Open Access

Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A

Subhashis Sarkar, Michel van Gelder, Willy Noort, Yunping Xu, Kasper M. A. Rouschop, Richard Groen, Harry C. Schouten, Marcel G. J. Tilanus, Wilfred T. V. Germeraad, Anton C. M. Martens, Gerard M. J. Bos, Lotte Wieten

01.08.2015 | Original Article | Ausgabe 8/2015

CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion

Fei Wang, Li Yang, Qun Gao, Lan Huang, Liping Wang, Jing Wang, Shengdian Wang, Bin Zhang, Yi Zhang

01.08.2015 | Original Article | Ausgabe 8/2015

Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer

Joseph P. Balint, Elizabeth S. Gabitzsch, Adrian Rice, Yvette Latchman, Younong Xu, Gerald L. Messerschmidt, Arvind Chaudhry, Michael A. Morse, Frank R. Jones

01.08.2015 | Original Article | Ausgabe 8/2015

Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation

Marilène Binsfeld, Muriel Hannon, Eléonore Otjacques, Stéphanie Humblet-Baron, Etienne Baudoux, Yves Beguin, Frédéric Baron, Jo Caers

01.08.2015 | Original Article | Ausgabe 8/2015

Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study

Riccardo Danielli, Roberto Patuzzo, Anna Maria Di Giacomo, Gianfranco Gallino, Andrea Maurichi, Annabella Di Florio, Ornella Cutaia, Andrea Lazzeri, Carolina Fazio, Clelia Miracco, Leonardo Giovannoni, Giuliano Elia, Dario Neri, Michele Maio, Mario Santinami

01.08.2015 | Original Article | Ausgabe 8/2015

Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis

Snezana Zivancevic-Simonovic, Olgica Mihaljevic, Ivana Majstorovic, Suzana Popovic, Slavica Markovic, Olivera Milosevic-Djordjevic, Zorica Jovanovic, Ljiljana Mijatovic-Teodorovic, Dusan Mihajlovic, Miodrag Colic

01.08.2015 | Original Article | Ausgabe 8/2015 Open Access

Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study

Katy J. McCann, Rosemary Godeseth, Lindsey Chudley, Ann Mander, Gianfranco Di Genova, Paul Lloyd-Evans, Jonathan P. Kerr, Vladimir B. Malykh, Matthew W. Jenner, Kim H. Orchard, Freda K. Stevenson, Christian H. Ottensmeier

01.08.2015 | Original Article | Ausgabe 8/2015 Open Access

6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice

Laura Jeanbart, Iraklis C. Kourtis, André J. van der Vlies, Melody A. Swartz, Jeffrey A. Hubbell

01.08.2015 | Original Article | Ausgabe 8/2015

Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial

Yoshinari Maeda, Kiyoshi Yoshimura, Hiroto Matsui, Yoshitaro Shindo, Takao Tamesa, Yukio Tokumitsu, Noriaki Hashimoto, Yoshihiro Tokuhisa, Kazuhiko Sakamoto, Kouhei Sakai, Yutaka Suehiro, Yuji Hinoda, Koji Tamada, Shigefumi Yoshino, Shoichi Hazama, Masaaki Oka

01.08.2015 | Original Article | Ausgabe 8/2015

STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice

Zili Wang, Esteban Celis

01.08.2015 | Meeting Report | Ausgabe 8/2015

Second meeting of the Spanish Immunotherapy Group GEIT (Grupo Español de Inmunoterapia), January 16, 2015, in Zaragoza, Spain

Alberto Anel, Luis Martínez-Lostao, Julián Pardo

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise